Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Analysis

What Anbio Biotechnology Class A Ordinary Shares does

Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.

Key metrics

ETFs linked to NNNN

Broad-market and Healthcare sector ETFs an investor holding Anbio Biotechnology Class A Ordinary Shares is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NNNN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Anbio Biotechnology Class A Ordinary Shares?

Anbio Biotechnology Class A Ordinary Shares trades under the ticker NNNN on NASDAQ.

Which exchange is NNNN listed on?

NNNN is listed on NASDAQ.

What sector does Anbio Biotechnology Class A Ordinary Shares operate in?

Anbio Biotechnology Class A Ordinary Shares is classified in the Healthcare sector (Medical - Instruments & Supplies industry).

How can PortView help analyze NNNN in a portfolio?

PortView shows NNNN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.